SCHEMBL613348

SCHEMBL613348

CCC1(C)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5756962 1.00
Hydrogen Sulfide SCHEMBL5678752 0.96
Ammonia Solution, Strong SCHEMBL354382 0.96
SCHEMBL8050124 0.96
SCHEMBL23655465 0.89 KDM4E (0.36)
SCHEMBL8052471 0.87 KDM4E (0.35)
SCHEMBL2289717 0.85
SCHEMBL597791 0.85
SCHEMBL22641360 0.84 KDM4E (0.33)
SCHEMBL16119813 0.84 KDM4E (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 206 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2829555-B1 METHOD FOR PRODUCING OLEFIN POLYMER MITSUI CHEMICALS INC (JP) 2018-05-16 EP claimed
EP-3089980-B1 SERINE/THREONINE KINASE INHIBITORS ARRAY BIOPHARMA INC (US) 2018-01-31 EP claimed
US-9670208-B2 Serine/threonine kinase inhibitors ARRAY BIOPHARMA INC. (US) 2017-06-06 US claimed
US-20160304519-A1 SERINE/THREONINE KINASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2016-10-20 US claimed
CN-104203993-B Process for producing olefin polymer 三井化学株式会社 2016-06-15 CN claimed
EP-2483531-A2 A HEAT RECOVERY SYSTEM BASED ON THE USE OF A STABILIZED ORGANIC RANKINE FLUID, AND RELATED PROCESSES AND DEVICES General Electric Company (US) 2012-08-08 EP claimed
US-20110072819-A1 HEAT RECOVERY SYSTEM BASED ON THE USE OF A STABILIZED ORGANIC RANKINE FLUID, AND RELATED PROCESSES AND DEVICES GENERAL ELECTRIC COMPANY (US) 2011-03-31 US claimed
WO-2011037709-A2 A HEAT RECOVERY SYSTEM BASED ON THE USE OF A STABILIZED ORGANIC RANKINE FLUID, AND RELATED PROCESSES AND DEVICES GENERAL ELECTRIC COMPANY (US) 2011-03-31 WO claimed
US-20090306442-A1 OLIGOMERISATION CATALYST WITH PENDANT DONOR GROUPS SASOL TECHNOLOGY (PTY) LIMITED (ZA) 2009-12-10 US claimed
EP-2024305-A2 OLIGOMERISATION CATALYST WITH PENDANT DONOR GROUPS Sasol Technology (Pty) Ltd (ZA) 2009-02-18 EP claimed
WO-2007138545-A2 OLIGOMERISATION CATALYST WITH PENDANT DONOR GROUPS SASOL TECHNOLOGY (PTY) LIMITED (ZA) 2007-12-06 WO claimed
CN-112543764-B Amide compound with BET proteolytic induction effect and medical application thereof 田边三菱制药株式会社 2024-05-10 CN disclosed
US-20230339884-A1 Triazole N-Linked Carbamoyl Cyclohexyl Acids as LPA Antagonists BRISTOL MYERS SQUIBB CO (US) 2023-10-26 US disclosed
US-11697646-B2 Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists BRISTOL-MYERS SQUIBB COMPANY (US) 2023-07-11 US disclosed
EP-3810283-B1 SOLID FORMS OF THE TARTRATE SALT OF 3-((1R,3R)-1-(2,6-DIFLUORO-4-((1-(3-FLUOROPROPYL)AZETIDIN-3-YL)AMINO)PHENYL)-3-METHYL-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOL-2-YL)-2,2-DIFLUOROPROPAN-1-OL, PROCESS FOR THEIR PREPARATION AND METHODS OF THEIR USE IN TREATING CANCERS HOFFMANN LA ROCHE (CH) 2023-06-14 EP disclosed
WO-2003032910-A2 CARBINOLS FOR THE TREATMENT OF NEUROPATHIC DYSFUNCTION ENDO PHARMACEUTICALS INC. (US) 2003-04-24 WO disclosed
EP-1289944-A2 THIOKETALS AND THIOETHERS FOR INHIBITING THE EXPRESSION OF VCAM-1 Atherogenics, Inc. (US) 2003-03-12 EP disclosed
EP-1213281-A1 NOVEL AMIDE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2002-06-12 EP disclosed
US-20020016300-A1 Thioketals and thioethers for inhibiting the expression of VCAM-1 CRABTREE ACQUISITION CO, LLC 2002-02-07 US disclosed
WO-2001070757-A2 THIOKETALS AND THIOETHERS FOR INHIBITING THE EXPRESSION OF VCAM-1 ATHEROGENICS, INC. (US) 2001-09-27 WO disclosed